13F Holdings
中文EN

WAT WATERS CORP /DE/

Laboratory Analytical Instruments · NYSE · SEC CIK 1000697 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY7.0%
TTM net income YoY0.8%
TTM EPS YoY0.5%
Revenue 3-yr CAGR2.1%
Net income 3-yr CAGR-3.2%

Margins

Gross margin59.3%
Operating margin25.4%
Net margin20.3%
FCF margin17.1%
EBITDA margin28.1%

Returns

ROE29.3%
ROA13.3%
ROIC (approx.)22.6%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets49.5%
Debt / equity0.37x
Current ratio1.73x
Interest coverage11.54x

Cash quality & payout

Operating cash flow / net income1.02x
Accruals ratio-0.2%
Payout ratio—
Capex / revenue3.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY2021*2021-12-31
Income statement
Revenue$3.17B$2.96B$2.96B$2.97B$2.79B
Cost of revenue$1.29B$1.20B$1.20B$1.25B$1.16B
Gross profit$1.88B$1.76B$1.76B$1.72B$1.63B
R&D expense$195.71M$183.03M$174.94M$176.19M$168.36M
SG&A expense$830.37M$690.15M$736.01M$658.03M$626.97M
Operating income$802.59M$826.35M$817.68M$873.39M$821.71M
Interest expense$69.55M$89.68M$98.86M$48.80M$44.94M
Pretax income$754.88M$754.87M$736.24M$837.85M$806.19M
Income tax$112.25M$117.03M$94.01M$130.09M$113.35M
Net income$642.63M$637.83M$642.23M$707.75M$692.84M
EBITDA$890.73M$913.37M$902.30M$945.39M$893.27M
EPS (basic)10.8010.7510.8711.8011.25
EPS (diluted)10.7610.7110.8411.7311.17
Weighted avg. shares (diluted)59.71M59.55M59.27M60.33M62.03M
Banking
Net interest income-$47.71M-$71.48M-$81.43M-$35.55M—
Balance sheet
Cash & equivalents$588.00M$325.00M$395.08M$480.53M$501.23M
Short-term investments—$934,000$898,000$862,000$68.05M
Receivables$829.00M$733.37M$702.17M$722.89M$612.65M
Inventory$572.00M$477.26M$516.24M$455.71M$356.10M
Current assets$2.15B$1.67B$1.75B$1.76B$1.63B
PP&E, net$642.00M$651.20M$639.07M$582.22M$547.91M
Goodwill$1.34B$1.30B$1.31B$430.33M$437.87M
Intangibles$558.00M$567.91M$629.19M$227.40M$242.40M
Total assets$5.08B$4.55B$4.63B$3.28B$3.09B
Current liabilities$1.24B$789.76M$789.58M$785.74M$680.51M
Short-term debt————$0
Long-term debt$947.00M$1.63B$2.31B$1.52B$1.51B
Total debt$947.00M$1.63B$2.31B$1.52B$1.51B
Total liabilities$2.52B$2.73B$3.48B$2.78B$2.73B
Shareholders' equity$2.56B$1.83B$1.15B$504.49M$367.55M
Net debt$359.00M$1.30B$1.91B$1.04B$1.01B
Shares outstanding59.55M59.39M59,17659.10M60.73M
Cash flow statement
Operating cash flow$652.55M$762.12M$602.81M$611.66M$747.27M
Capital expenditure$112.75M$142.48M$160.63M——
Free cash flow$539.81M$619.64M$442.18M——
Investing cash flow-$152.25M-$143.09M-$1.44B-$107.97M-$231.63M
Financing cash flow-$237.21M-$696.67M$754.95M-$509.63M-$438.27M
Depreciation & amortization$88.14M$87.02M$84.62M$72.00M$71.56M
Stock-based compensation$54.13M$44.71M$36.87M$42.56M$29.92M
Share buybacks$14.67M$13.54M$70.28M$626.06M$648.93M

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.